Mati Therapeutics
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
101 Colorado St Apt 2409, Austin, Texas,...Phone Number
(512) 720-1333Website
www.matitherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Mati Therapeutics
Mati Therapeutics, based in Austin, Texas, specializes in developing a non-invasive sustained drug delivery platform aimed at treating ocular diseases, particularly glaucoma. The company has created the Evolute Punctal Plug Delivery System, a discreet device that automatically administers medication over an extended period, alleviating the need for patients or caregivers to use eye drops. With a leadership team boasting over a century of combined experience in ophthalmology, Mati is committed to enhancing treatment outcomes for patients with ocular disorders. Their innovative approach addresses the significant global issue of vision impairment, which affects over 1 billion people worldwide.Explore more
Mati Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mati Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Mati Therapeutics recently announced quarterly report
Click to see if Mati Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Mati Therapeutics has new funding data
Product Launch: Get notified when Mati Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Mati Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mati Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Mati Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Mati Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Mati Therapeutics
Find 2 more new buyers
Compare Similar Companies to Mati Therapeutics
Compare insights from companies similar to Mati Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mati Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mati Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mati Therapeutics.
Mati Therapeutics financials insights
Gather financial insights about Mati Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Private Equity
$1.3M
2025
Stock/Share Issuance
$2.2M
Stock/Share Issuance
$9.9M
Mati Therapeutics Tech Stack
A closer look at the technologies used by Mati Therapeutics
Most Recent Scoops
Funding
Funding
Funding
Funding
Promotion
Executive Move
Promotion
Executive Move
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mati Therapeutics
Sign Up For FreeTo access detailed company insights
Mati Therapeutics, based in Austin, Texas, specializes in developing a non-invasive sustained drug delivery platform aimed at treating ocular diseases, particularly glaucoma. The company has created the Evolute Punctal Plug Delivery System, a discreet device that automatically administers medication over an extended period, alleviating the need for... Read More
